BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33845139)

  • 1. TWIST1-mediated transcriptional activation of PDGFRβ in breast cancer stem cells promotes tumorigenesis and metastasis.
    Yeeravalli R; Kaushik K; Das A
    Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166141. PubMed ID: 33845139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.
    Li LZ; Zhang CZ; Liu LL; Yi C; Lu SX; Zhou X; Zhang ZJ; Peng YH; Yang YZ; Yun JP
    Carcinogenesis; 2014 Feb; 35(2):469-78. PubMed ID: 24085799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The miR-5694/AF9/Snail Axis Provides Metastatic Advantages and a Therapeutic Target in Basal-like Breast Cancer.
    Tian X; Yu H; Li D; Jin G; Dai S; Gong P; Kong C; Wang X
    Mol Ther; 2021 Mar; 29(3):1239-1257. PubMed ID: 33221433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long noncoding RNA TUG1 is required for TGF-β/TWIST1/EMT-mediated metastasis in colorectal cancer cells.
    Shen X; Hu X; Mao J; Wu Y; Liu H; Shen J; Yu J; Chen W
    Cell Death Dis; 2020 Jan; 11(1):65. PubMed ID: 31988275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1.
    Li CW; Xia W; Huo L; Lim SO; Wu Y; Hsu JL; Chao CH; Yamaguchi H; Yang NK; Ding Q; Wang Y; Lai YJ; LaBaff AM; Wu TJ; Lin BR; Yang MH; Hortobagyi GN; Hung MC
    Cancer Res; 2012 Mar; 72(5):1290-300. PubMed ID: 22253230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The twist box domain is required for Twist1-induced prostate cancer metastasis.
    Gajula RP; Chettiar ST; Williams RD; Thiyagarajan S; Kato Y; Aziz K; Wang R; Gandhi N; Wild AT; Vesuna F; Ma J; Salih T; Cades J; Fertig E; Biswal S; Burns TF; Chung CH; Rudin CM; Herman JM; Hales RK; Raman V; An SS; Tran PT
    Mol Cancer Res; 2013 Nov; 11(11):1387-400. PubMed ID: 23982216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
    Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A
    Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pterostilbene, a bioactive component of blueberries, suppresses the generation of breast cancer stem cells within tumor microenvironment and metastasis via modulating NF-κB/microRNA 448 circuit.
    Mak KK; Wu AT; Lee WH; Chang TC; Chiou JF; Wang LS; Wu CH; Huang CY; Shieh YS; Chao TY; Ho CT; Yen GC; Yeh CT
    Mol Nutr Food Res; 2013 Jul; 57(7):1123-34. PubMed ID: 23504987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer.
    Camorani S; Passariello M; Agnello L; Esposito S; Collina F; Cantile M; Di Bonito M; Ulasov IV; Fedele M; Zannetti A; De Lorenzo C; Cerchia L
    J Exp Clin Cancer Res; 2020 Sep; 39(1):180. PubMed ID: 32892748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1.
    Pei XH; Lv XQ; Li HX
    Biochem Biophys Res Commun; 2014 Mar; 446(1):322-7. PubMed ID: 24607904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis.
    Tsai JH; Donaher JL; Murphy DA; Chau S; Yang J
    Cancer Cell; 2012 Dec; 22(6):725-36. PubMed ID: 23201165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1.
    Velpula KK; Dasari VR; Tsung AJ; Dinh DH; Rao JS
    Oncotarget; 2011 Dec; 2(12):1028-42. PubMed ID: 22184289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence.
    Tran DD; Corsa CA; Biswas H; Aft RL; Longmore GD
    Mol Cancer Res; 2011 Dec; 9(12):1644-57. PubMed ID: 22006115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.
    Guo BH; Feng Y; Zhang R; Xu LH; Li MZ; Kung HF; Song LB; Zeng MS
    Mol Cancer; 2011 Jan; 10(1):10. PubMed ID: 21276221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells.
    Park SY; Kim MJ; Park SA; Kim JS; Min KN; Kim DK; Lim W; Nam JS; Sheen YY
    Oncotarget; 2015 Nov; 6(35):37526-43. PubMed ID: 26462028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.
    Vesuna F; Lisok A; Kimble B; Raman V
    Neoplasia; 2009 Dec; 11(12):1318-28. PubMed ID: 20019840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twist1-induced invadopodia formation promotes tumor metastasis.
    Eckert MA; Lwin TM; Chang AT; Kim J; Danis E; Ohno-Machado L; Yang J
    Cancer Cell; 2011 Mar; 19(3):372-86. PubMed ID: 21397860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma.
    Banerjee A; Wu ZS; Qian P; Kang J; Pandey V; Liu DX; Zhu T; Lobie PE
    Breast Cancer Res; 2011; 13(6):R112. PubMed ID: 22060274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIN1 Inhibition Sensitizes Chemotherapy in Gastric Cancer Cells by Targeting Stem Cell-like Traits and Multiple Biomarkers.
    Zhang ZZ; Yu WX; Zheng M; Liao XH; Wang JC; Yang DY; Lu WX; Wang L; Zhang S; Liu HK; Zhou XZ; Lu KP
    Mol Cancer Ther; 2020 Mar; 19(3):906-919. PubMed ID: 31879364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.